These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20335563)

  • 1. Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients.
    Saver JL; Barsan WG
    Neurology; 2010 Apr; 74(17):1336-7. PubMed ID: 20335563
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.
    Isayev Y; Conahan E; Mathiesen C; Jenny D; Castaldo J
    Neurology; 2010 Nov; 75(20):1853-4; author reply 1854. PubMed ID: 21121100
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.
    Martinez-Ramirez S; Delgado-Mederos R; Martí-Vilalta JL; Martí-Fàbregas J
    Neurology; 2010 Nov; 75(20):1853; author reply 1854. PubMed ID: 21079190
    [No Abstract]   [Full Text] [Related]  

  • 4. Right brain: my first tPA.
    Robbins MS
    Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 6. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
    Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic treatment in everyday clinical practice--efficacious and safe?].
    Grond M
    Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S129-31. PubMed ID: 17089257
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute ischemic stroke, Part 1.
    Fullerton T
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):571-2. PubMed ID: 8908931
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physiopathology of cerebral ischemia: what is the contribution of future treatments?].
    Deplanque D
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F133-9. PubMed ID: 19593882
    [No Abstract]   [Full Text] [Related]  

  • 14. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

  • 15. A tale of two emergency visits.
    Reid SM
    CJEM; 2014 May; 16(3):183-4. PubMed ID: 24852580
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
    Ribo M; Molina CA; Delgado P; Rubiera M; Delgado-Mederos R; Rovira A; Munuera J; Alvarez-Sabin J
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute embolic stroke treated with rt-PA during elective coronary angiography].
    Ascer E; Lessa I; Caldas JG; Frudit ME; Pereira Mde B; Baruzzi AC
    Arq Bras Cardiol; 1996 Sep; 67(3):171-3. PubMed ID: 9181710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteplase for thrombolysis in acute ischemic stroke.
    Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.